About   Help   FAQ
Phenotypes Associated with This Genotype
Genotype
MGI:3613697
Allelic
Composition
Dmpktm1Rdd/Dmpktm1Rdd
Genetic
Background
involves: 129S2/SvPas * C57BL/6J
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Dmpktm1Rdd mutation (0 available); any Dmpk mutation (37 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
muscle
• ultrastructurally, affected sternomastoid muscles exhibit loss of sarcomeric organization and abnormal mitochondria
• ultrastructurally, affected sternomastoid muscles exhibit focal loss of Z lines
• ultrastructurally, affected sternomastoid muscles exhibit dilation of the sarcoplasmic reticulum
• at 7-11 months, sternomastoid muscles from older (but not younger) homozygote exhibit increased variability in fiber size, with the mean fiber area ranging from 0.7 to 1.5 that of wild-type mice; no significant differences are noted in fiber type distribution or fiber total number
• in vitro, sternomastoid muscles from young (3- to 4-mo-old) homozygotes show no significant differences in isometric twitch or tetanic force, contraction or relaxation times relative to wild-type muscles
• in contrast, sternomastoid muscles from older (7- to 11-mo-old) homozygotes show a 30%-50% reduction in twitch and tetanic force generation relative to wild-type muscles
• homozygotes exhibit a progressive increase in skeletal muscle regenerative activity, as shown by a 3-4-fold increase of MyoD levels in neck, fore- and hindlimb muscles from 7- to 11-mo-old (but not younger) mutants relative to wild-type mice
• consistent with increased MyoD levels, a large proportion of fibers (1%) in sternomastoid muscles from older homozygotes express embryonic MHC vs only 0.4% of fibers in wild-type muscles, suggesting an increased incidence of muscle fiber regeneration over time
• homozygotes exhibit progressive muscle weakness in the absence of a generalized neuropathy, neuromuscular junction transmission defects, abnormal neuromuscular innervation or reduced muscle fiber membrane electrical excitability
• homozygotes display late-onset, progressive degenerative changes in skeletal muscle, including variation in fiber diameter, increased foci of degeneration/regeneration and increased fibrosis; no myotonia is ever observed

cardiovascular system
• adult homozygotes display distinct atrioventricular conduction abnormalities in the presence of normal intrinsic sinus node function
• no increased fibrosis, atrophy or altered cardiac function, chamber dimensions, wall thickness, or ventricular shortening are observed
• adult homozygotes exhibit delayed atrioventricular (A-V) conduction, manifest as first-degree (10 of 10), second-degree (5 of 17), and third-degree (2 of 17) atrioventricular block
• on ECGs, all adult homozygotes exhibit a prolonged mean P-R interval of 48 7 ms (first-degree A-V block) vs 34 5 ms in wild-type mice; in contrast, basal heart rate, P-wave duration and other ECG intervals (QRS, J-T, Q-T) remain unaffected
• a trend towards an increase in P-R intervals is noted with age, such that P-R intervals of >50 ms are not observed at 6 months, and become apparent only at 16-17 months of age
• second- and third-degree heart block occurs at a higher frequency in 16-17-month-olds and primarily in mice with a P-R interval greater than or equal to 45 ms
• no further progression of higher-grade A-V block is noted during rest, ambulation, or graded exercise testing
• left ventricle SR vesicles from 12-week-old male homozygotes show a ~2-fold decrease in phospholamban phosphorylation activity, as commonly found in acquired forms of heart failure

homeostasis/metabolism
• mutant ventricular homogenates exhibit significantly reduced Ca2+ uptake in cardiomyocyte sarcoplasmic reticulum (SR), with a 48% and 84% decrease at 200 and 20 nM free calcium concentrations, respectively, relative to wild-type
• reduced SR Ca2+ uptake is detected at 14 weeks of age i.e. prior to the first detectable signs of muscle weakness observed at 7-10 months

Mouse Models of Human Disease
DO ID OMIM ID(s) Ref(s)
myotonic dystrophy type 1 DOID:11722 OMIM:160900
J:33714 , J:53077


Contributing Projects:
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO)
Citing These Resources
Funding Information
Warranty Disclaimer, Privacy Notice, Licensing, & Copyright
Send questions and comments to User Support.
last database update
12/10/2024
MGI 6.24
The Jackson Laboratory